Tumor necrosis factor: Difference between revisions

Michal Harel (talk | contribs)
No edit summary
Michal Harel (talk | contribs)
No edit summary
Line 1: Line 1:
<StructureSection load='2az5' size='350' side='right' caption='Structure of human tumor necrosis factor tetramer complex with inhibitor (PDB entry [[2az5]])' scene=''>
<StructureSection load='2az5' size='350' side='right' caption='Structure of human tumor necrosis factor tetramer complex with inhibitor (PDB entry [[2az5]])' scene=''>
== Function ==
== Function ==
'''Tumor necrosis factor''' (TNF) is a cytokine which can cause apoptosis.  '''TNFα''' is implicated in tumor regression, septic shock, inflammation and cachexia (wasting syndrome).  It is involved in the regulation of the immune cells<ref>PMID:11514191</ref>.  TNF is a transmembrane homotrimer.  The soluble TNF is produced by cleavage by the metalloprotease TNFα-converting enzyme (TACE or ADAM17 see [[A Disintegrin And Metalloproteinase]]).   
'''Tumor necrosis factor''' (TNF) is a cytokine which can cause apoptosis.  '''TNFα''' is implicated in tumor regression, septic shock, inflammation and cachexia (wasting syndrome).  It is involved in the regulation of the immune cells<ref>PMID:11514191</ref>.  '''TNFβ''' is inhibited by interleukin 10.  TNF is a transmembrane homotrimer.  The soluble TNF is produced by cleavage by the metalloprotease TNFα-converting enzyme (TACE or ADAM17 see [[A Disintegrin And Metalloproteinase]]).   


== Relevance ==
== Relevance ==
Line 12: Line 12:
{{#tree:id=OrganizedByTopic|openlevels=0|
{{#tree:id=OrganizedByTopic|openlevels=0|


*TNF alpha
*TNF α


**[[1tnf]] – hTNF – human  <BR />
**[[1tnf]] – hTNF – human  <BR />
Line 24: Line 24:
**[[4twt]] – hTNF + peptide  <BR />
**[[4twt]] – hTNF + peptide  <BR />


*TNF beta
*TNF β


**[[1tnr]] – hTNF + TNF receptor p55  <BR />
**[[1tnr]] – hTNF + TNF receptor p55  <BR />

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky, Joel L. Sussman